Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is well-positioned for future growth, with a diverse portfolio of acute and chronic therapies and a distribution network spanning across 43 states. Their recent acquisition and integration with BioScrip has also expanded their reach and capabilities. However, there are potential risks from competition and changes in specialty therapy utilization that could impact their profitability. Further success in their Advanced Practitioner model and consistent positive performance could drive potential upside.

Bears say

Option Care Health is facing a mixed bag in the first quarter and has given lower guidance for 2026 due to lower revenue expectations. Their adjusted EPS and EBITDA remain unchanged, but their cash flow from operations has been reduced. With their share price dropping 24%, this may be seen as a buying opportunity, but with lower revenue and disruptions in the market, it may be difficult for the company to achieve their expected growth in the future.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.